Navigation Links
XL Advantage 4.5x @ 42cm working distance

ProductsXL Advantage 4.5x @ 42cm working distance
Company Keeler Instruments Inc.
Item XL Advantage 4.5x @ 42cm working distance
Features Ease back pain with a choice of working distances to suite all posture requirements, while maintaining your working distance, vision into the base of the surgical field is clear and precise, with autoclavable protection caps, your magnification systems are protected in all circumstances, the caps are sterilisable to avoid contamination, the unique feature of our distance caps enable you to decrease your working distance by up to 10 cm - ideal for surgical procedures requiring a sitting or standing position, the autoclavable flip lever means magnification can easily be flipped from your line of sight, simply flip down again when required. Lightweight, spring sided, comfortable frames are available in small, medium and large sizes, glazed with protective lenses.
Description The XL Advantage delivers higher magnification for advanced surgical procedures. Prismatic quality guarantees a crisp, true image, even at the highest magnification. 3.5x, 4.5x and 5.5x. Edge to edge clarity and precise color rendition is ideal for surgical applications. Precision lenses treated with an anti-reflective coating produce a superior image. The compact abd lightweight design provides optical stability and comfort. Ideal for fine nerve repair, vascular surgery and pediatrics.
Info Keeler Instruments Inc.
Customer Service: (800) 523-5620
Web site: http://www.keelerusa.com

Related medicine products :

1. XL Advantage 3.5x @ 34cm working distance
2. XL Advantage Prismatic
3. XL Advantage 3.5x @ 46cm working distance
4. XL Advantage 4.5x @ 34cm working distance
5. XL Advantage 4.5x @ 46cm working distance
6. XL Advantage 5.5x @ 34cm working distance
7. XL Advantage 5.5x @ 42cm working distance
8. XL Advantage 5.5x @ 46cm working distance
9. MultiWash Advantage
10. XL Advantage
11. The Global Advantage Shoulder System
... cup system has been designed to enhance ... and cluster hole configurations. The objective of ... on three primary modes: Tilt, migration and ... result in initial and long-term fixation. The ...
Optimal solution for normal acetabulum and younger patients....
Biopro rimmed acetabular is manufactured from titanium and is porous coated on the outside of its shell. The rimmed acetabular accommodates a polyethylene inert....
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Medicine Products:
(Date:10/2/2014)... Robins & Morton received nine Excellence ... Contractors (ABC) of Alabama. , ABC will recognize ... Sheraton Birmingham Hotel., ,     HealthSouth Rehabilitation ... $25 Million, Obelisk Award (First Place) , ... Million to $25 Million, Obelisk Award (First Place) ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. ... control -- especially long-acting implanted devices -- could slash pregnancy ... new findings suggest. In a study of 1,400 teenage ... the girls, rates of unplanned pregnancy and abortion. Over three ... -- versus a rate of 158 per 1,000 among all ...
(Date:10/2/2014)... 1, 2014 (HealthDay News) -- Children with autism are ... fully capable of being more active, a small study ... of 29 children, some with autism and some without. ... of moderate physical activity and 70 more minutes each ... children with autism scored lower on strength, but had ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... that pull out all the stops to rescue surgical ... but the cost of such heroism is questionable, a ... 5 percent better at saving elderly patients with life-threatening ... with less intensity, said senior author Dr. Amir Ghaferi. ...
(Date:10/1/2014)... strongly associated with Alzheimer,s disease; however, researchers are still ... causal agent of the onset and development of the ... beta-amyloid is not harmful when found in isolation but ... to form the so-called amyloid fibrils , "We are ... with multiple ones because each aggregate of peptide, which ...
Breaking Medicine News(10 mins):Health News:Robins & Morton wins nine awards from Associated Builders and Contractors 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 3Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 4Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... IntraHealth International will highlight its ... the developing world during the 36th annual ... D.C., May 26-30. Hosted by the Global Health ... = Healthy Communities," focuses on the ways in which ...
... groups, headed by Prof. Nils Brose of the Max Planck ... on behalf of the European Union, to study the role ... the research teams is headed by Prof. Kobi Rosenblum of ... has been awarded a grant of 600,000 Euro. The topic ...
... reports MS medication possession ratio of 86 percent for ... Multiple sclerosis patients managed by a specialty pharmacy program ... risk of being hospitalized for their disease than those ... according to a study completed by HealthCore, Inc.HealthCore researcher ...
... Velocity,s intelligent search capabilities such as geo-spatial search, content ... May 19 Vivisimo ( www.vivisimo.com ), a leading ... that Bupa, an international health and care company with ... selected the Vivisimo Velocity Search Platform ...
... to provide sun protection, laughs and college scholarship ... Today non-profit Cancer for College launches a new ... proceeds from the sunscreen sales will go to ... granting college scholarships to cancer survivors and amputees.To ...
... mice might explain progression from skin to breathing condition ... secreted by eczema-damaged skin might trigger asthma in children, ... study of mice with an eczema-like condition, which suggested ... trigger substance might help prevent asthma. , An estimated ...
Cached Medicine News:Health News:IntraHealth International Addresses Capacity Building and Open Source Technologies at Tech-Themed Global Health Conference 2Health News:MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR 2Health News:MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR 3Health News:Vivisimo Powers Site Search on Bupa's Leading Health Information Websites Worldwide 2Health News:Photos: Will Ferrell Sunscreen to Launch Just in Time for Summer 2Health News:Molecule in Skin May Link Eczema and Asthma 2
(Date:10/2/2014)... Research and Markets  has announced the ... by Application, and by Geography - Global Forecast to ... The medical electronics market is expected to grow at ... the world due to growing income levels, and increasing ... hypertension, and cardiovascular diseases. A growing population coupled with ...
(Date:10/2/2014)... 2, 2014  Eli Lilly and Company (NYSE: ... tabalumab­ -- being studied for the treatment of ... -- due to insufficient efficacy in two pivotal ... on safety concerns. ­­­­ In the ... primary endpoint, at either dose studied, of statistically ...
(Date:10/2/2014)...  InfinityQS International, Inc., the global authority on ... client speakers for Infusion Chicago, its 9 th ... will be held Oct. 9-10, 2014, at the ... from Coloplast, The Kellogg Company, Biomet, General Cable, ... two-day event will also include best practice presentations ...
Breaking Medicine Technology:Medical Electronics (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU) Market - Global Forecast to 2020 2Medical Electronics (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU) Market - Global Forecast to 2020 3Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 2Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 3InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 2InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 3